CRP and cancer: Additionally, CRP, with its reliability for prognosis forecasting in cancer [44], has been confirmed to be significantly and positively associated with several fields in the EORTC QLQ-C30 assessment (fatigue, nausea, and vomiting, pain, dyspnea, insomnia, appetite loss, diarrhea, and financial difficulty), while being significantly and negatively associated with physical functioning, role functioning, cognitive functioning, social functioning, and global QoL [46].